Current indications for hand and face allotransplantation

Area of Science:

• Regenerative Medicine
• Transplantation Surgery
• Immunology

Background:

• Composite tissue allotransplantation (CTA) is gaining traction in US medical centers.
• Developing clear patient selection criteria for CTA is essential as programs emerge.
• Contraindications for CTA are currently better defined than indications.

Purpose of the Study:

• To highlight the need for robust patient selection guidelines in CTA.
• To emphasize the importance of a comprehensive multidisciplinary approach for CTA candidates.
• To discuss the surgeon's role in assessing CTA feasibility against conventional methods.

Main Methods:

• Review of current practices and challenges in CTA patient selection.
• Discussion of multidisciplinary evaluation protocols.
• Comparison of CTA with established reconstructive surgical techniques.

Main Results:

• Patient selection for CTA requires a thorough assessment of defect complexity and global impact.
• Surgeons must weigh CTA feasibility against expertise in conventional reconstructive options.
• Conventional treatments can serve as alternatives or salvage options for CTA.

Conclusions:

• Standardized indications for CTA are needed to complement existing contraindications.
• Multidisciplinary assessment is paramount for successful CTA patient selection.
• Surgical decision-making must integrate CTA potential with conventional reconstructive expertise.